ReviewReviews in cardiovascular medicine2026
Advances in Non-Invasive Myocardial Stiffness Assessment and Clinical Applications in Hypertrophic Cardiomyopathy.
Review in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial stiffness is a central determinant of diastolic dysfunction and clinical outcomes in hypertrophic cardiomyopathy; however, a non-invasive evaluation of myocardial stiffness remains challenging. Emerging techniques, such as elastography, offer direct, non-invasive quantification of myocardial stiffness, providing critical insights beyond conventional indirect surrogates. This review summarizes the principles, validation, and clinical evidence for current non-invasive techniques for assessing myocardial stiffness. We further discuss the clinical applications of these techniques in hypertrophic cardiomyopathy, including diagnostic refinement, fibrosis detection, risk stratification, and treatment monitoring, as well as the challenges and future directions required for broader clinical translation. Ultimately, the non-invasive assessment of myocardial stiffness holds promise for transforming patient management to phenotyping and therapeutic decision-making through a more precise, mechanism-based approach.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.